News | September 20, 2021
U.S. FDA concludes inspection of Lupin’s Goa facility with seven observations
The company said in a regulatory filing that it was confident of addressing the observations satisfactorily
The company said in a regulatory filing that it was confident of addressing the observations satisfactorily
Tagrisso plus chemotherapy achieves nearly four-year median overall survival in EGFR-mutated advanced lung cancer, setting new global standard in phase III trial
The portfolio acquired includes Stugeron brand as well as its leading local brands STUGERON FORTE and STUGERON PLUS across 18 markets in the APAC and EMEA regions
These licenses are given in areas of infectious disease diagnostics, immunodiagnostics, and vaccine development
Phase 1 has a total reactor capacity of 440 kL with 63 reactors
Enlicitide achieved all primary and key secondary endpoints, demonstrating statistically significant and clinically meaningful reductions in low-density lipoprotein cholesterol
It offers clear environmental benefits, lower emissions, reduced hazardous material use, and alignment with circular economy goals
This year’s edition will witness participation of over 700 Indian exporters showcasing their products and services; 500+ overseas delegates representing more than 120 countries; 20,000 domestic visitors; and 8,000+ B2B meetings
Treatment with Verzenio also resulted in sustained invasive disease-free survival and distant relapse-free survival benefit
WIDAPLIK is the first and only FDA-approved triple combination medication for use as an initial therapy in patients likely to need multiple drugs to achieve blood pressure goals
Subscribe To Our Newsletter & Stay Updated
